Chemfab Alkalis Q3FY26: Investor Presentation Released
Chemfab Alkalis released its Q3FY26 investor presentation for the quarter ended December 31, 2025. Key developments include the completion of technology modernization and upcoming hybrid power plant. The company expects gradual performance improvement from Q4FY26, driven by stabilizing realisations and operational efficiencies.
The investor presentation provides detailed financial and operational updates, including segment performance and strategic plans. This information is material for investors assessing the company's current standing and future prospects, thus having a medium impact.
The announcement is an investor presentation, providing an update on the company's performance and outlook. While it highlights ongoing improvements and strategic initiatives, it also acknowledges soft market conditions and delays in certain segments, resulting in a neutral sentiment.
Chemfab Alkalis Limited has submitted an investor presentation for the quarter ended December 31, 2025. The presentation, which is also available on the company's website (https://chemfabalkalis.com/), offers insights into the company's performance and strategic initiatives.
During Q3FY26, global caustic prices remained soft, though ECU realization improved sequentially to ₹38,500 per MT from ₹36,700 per MT, supported by stronger chlorine realizations. Global caustic prices are perceived to have bottomed out, indicating potential for recovery. The Technology Modernisation Programme has been successfully completed with the new plant commissioned on December 30, 2025, expected to enhance operational efficiencies and volumes. The Captive Hybrid Power Plant is ready and anticipated to commence power supply from Q4FY26, promising significant cost savings.
The OPVC segment experienced slower business under the Jal Jeevan Mission due to delayed fund flows, with demand revival expected after the upcoming budget. However, the company has grown OPVC volumes through projects outside the Jal Jeevan Mission. The consolidated performance is seen as having reached a trough, with gradual improvement expected in the coming quarters, driven by stabilizing realisations, modernized facilities, and hybrid power supply. The coming year is projected to be stronger for the OPVC business as demand normalizes.
The company's financial highlights for Q3FY26 show a consolidated revenue from operations of ₹62.17 crore, with an operational EBITDA of ₹5.17 crore and an EBITDA margin of 8.32%. The Chlor-Alkali segment revenue was ₹47.52 crore with an operational EBITDA of ₹1.77 crore and a 3.72% margin. The OPVC segment revenue was ₹14.65 crore with an operational EBITDA of ₹3.40 crore and a 23.21% margin.
Strategic initiatives include optimizing the Chlor-Alkali business through technology modernization (₹60 crore investment, expected completion July 2025) and investing in a hybrid power project. The OPVC Pipes business is undergoing rapid capacity expansion, scaling from 14,000 TPA in FY25 to 23,000 TPA in FY26, with plans for a potential Central India facility. The company continues to leverage its partnership with Molecor Tecnología S.L. for advanced manufacturing and aims for market penetration through government initiatives like Jal Jeevan Mission and AMRUT 2.0.
What to do with a filing like this
Chemfab Alkalis Limited filed this with the NSE as a statutory disclosure, categorised under investor presentation. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Chemfab Alkalis Limited. Read the original for the full detail.